Multiple sclerosis in 2018: new therapies and biomarkers
Sign Up to like & getrecommendations! Published in 2019 at "The Lancet Neurology"
DOI: 10.1016/s1474-4422(18)30455-1
Abstract: 2018 has been a year of substantial progress in multiple sclerosis research, with breakthroughs in experimental medicine and translational research. Advances have ranged from successful clinical trials to new reports of promising biomarkers and improved… read more here.
Keywords: new therapies; 2018 new; therapies biomarkers; sclerosis ... See more keywords